Skip to main content
SpringerLink
Log in

Keine erhöhte Rate an Sekundärmalignomen nach pelviner Radiotherapie

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Berrington de Gonzalez A, Curtis RE, Kry SF et al (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12:353–360

    Article  PubMed  Google Scholar 

  2. Brown AP, Neeley ES, Werner T et al (2010) A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. Int J RadiatOncolBiolPhys 78:127–135

    Google Scholar 

  3. Deutsch M, Land SR, Begovic M et al (2003) The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 98:1362–1368

    Article  PubMed  Google Scholar 

  4. Kendal WS, Nicholas GA (2007) Population-based analysis of second primary cancers after irradiation for rectal cancer. Am J ClinOncol 30:333–339

    Article  Google Scholar 

  5. Kumar S, Shah JP, Bryant CS et al (2009) Second neoplasms in survivors of endometrial cancer: impact of radiation therapy. GynecolOncol 113:233–239

    Google Scholar 

  6. Liu L, Vries E de, Louwman M et al (2011) Prevalence of multiple malignancies in the Netherlands in 2007. Int J Cancer 128:1659–1667

    Article  CAS  PubMed  Google Scholar 

  7. o A (2014) S 3-Leiltinie Prostatakarzinom.Langversion 3.1–2. Aktualisierung – Oktober, http://leitlinienprogramm-onkologie.de/uploads/tx_sbdownloader/LL_Prostata_Langversion_3.1.pdf. Zugegriffen: 30. Dez 2014

  8. Wiltink LM, Nout RA, Fiocco M et al (2014) No increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 trials. J ClinOncol http://www.ncbi.nlm.nih.gov/pubmed/25534376

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie des UKSH Kiel & Lübeck, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland

    Karen Huber &  Jürgen Dunst

Authors
  1. Karen Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen Dunst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen Huber.

Ethics declarations

Interessenkonflikt

K. Huber und J. Dunst geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Wiltink LM, Nout RA, Fiocco M et al (2014) No increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 trials. J ClinOncol (Epub ahead of print)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huber, K., Dunst, J. Keine erhöhte Rate an Sekundärmalignomen nach pelviner Radiotherapie. Strahlenther Onkol 191, 380–381 (2015). https://doi.org/10.1007/s00066-015-0821-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-015-0821-7

Search

Navigation